Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease



Fig. 4.1
Office BP values at follow-up. Changes in average office BP (a) and mean decrease in office BP (b) at follow-up. Error bars represent SDs. *P < 0.001 versus baseline (before the procedure). FU follow-up, M month, pre-RDN prerenal denervation. (Reprinted from [53]. With permission from the American Society of Nephrology)



Some concerns of this methodology specifically for CKD patients have to considered. First, in patients with low GFR renal blood flow can be particularly reduced. Since cooling of the catheter tip depends decisively on the blood flow, thermal problems might occur increasing the potential for damage of the renal blood vessels. Second, the procedure requires substantial amounts of contrast media raising the risk of acute kidney injury in these patients. Of interest, Hering et al. observed no deterioration in renal function over the course of the study in CKD patients.

The Simplicity Study III, a randomized controlled study, failed to demonstrate a beneficial effect of renal denervation on BP in a large group of patients with resistant hypertension [54]. Given these unimpressive results, the role of renal denervation in the management of resistant hypertension, particularly in CKD patients, remains to be established. Several issues need to be resolved: first, how to identify patients with increased renal sympathetic nerve activity , who may be more suitable for renal denervation; second, to what extent and with what variability renal denervation is achieved with the Simplicity catheter by various investigators; third, the issue of regeneration of renal nerves after denervation remains unresolved. Until all these issues are satisfactorily resolved, renal denervation should remain an experimental tool in the management of hypertension associated with kidney disease .



References



1.

Recordati G, Moss NG, Genovisi S, Rogenes P. Renal chemoreceptors. J Auton Nerv Syst. 1981;3:237–51.CrossRefPubMed


2.

Katholi RE. Renal nerves and hypertension: an update. Fed Proc. 1985;44:2846–50.PubMed


3.

Faber JE, Brody MJ. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res. 1985;57:676–88.CrossRefPubMed


4.

Calaresu FR, Ciriello J. Renal afferent nerves affect discharge rate of medullary and hypothalamic single uits in cat. J Auton Nerv Syst. 1981;3:311–20.CrossRefPubMed


5.

Katholi RE, Whitlow PL, Hageman GR, Woods T. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves. J Hypertens. 1984;2:349–59.CrossRefPubMed


6.

Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol. 1994;4:1901–7.PubMed


7.

Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. 1997;51:722–7.CrossRefPubMed


8.

Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis. 1995;26:861–5.CrossRefPubMed


9.

Ye S, Gumburd M, Campese VM. An acute renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens. 1998;11:723–8.CrossRefPubMed


10.

Lake CR, Ziegler MG, Coleman MD, Kopin IJ. Plasma levels of norepinephrine and dopamine-beta-hydroxylase in CRF patients treated with dialysis. Cardiovasc Med. 1979;1:1099–111.


11.

Henrich WL, Katz FH, Molinoff PB, Schrier RW. Competitive effects of hypokalemia and, depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients. Kidney Int. 1977;12:279–84.CrossRefPubMed


12.

Lzzo JL, Izzo MS, Sterns RH, Freeman RB. Sympathetic nervous system hyperactivity in maintenance hemodialysis patients. Trans Am Soc Artif Intern Organs. 1982;28:604–7.


13.

Ishii M, Ikeda T, Takagi M. Elevated plasma catecholamines in hypertensives with primary glomerular diseases. Hypertension. 1983;5:545–51.CrossRefPubMed


14.

Cuche JL, Prinseau J, Selz F, Ruget G, Baglin A. Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients. Kidney Int. 1986;30:566–72.CrossRefPubMed


15.

Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int. 1981;20:246–53.CrossRefPubMed


16.

Grekas D, Kalevrosoglou I, Karamouzis M, et al. Effects of sympathetic and plasma renin activity on hemodialysis hypertension. Clin Nephrol. 2001;55:115–20.PubMed

Oct 11, 2016 | Posted by in NEPHROLOGY | Comments Off on Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access